ELISA Kit for Neurotensin Receptor 1, High Affinity (NTSR1)

Assay length:

3h

Detection range:

0.156-10ng/mL

Research Area:

Neuro science;

Organism species:

Homo sapiens (Human)

Method:

Double-antibody Sandwich

Format:

48T, 96T, 96T×5, 96T×10, 96T×100

Item Name:

Neurotensin Receptor 1, High Affinity

Application:

Enzyme-linked immunosorbent assay for Antigen Detection.

Sample type:

Tissue homogenates, cell lysates and other biological fluids.

Sensitivity:

The minimum detectable dose of this kit is typically less than 0.061ng/mL

Alternative Names:

NTR; NTRH; NTRR; High-affinity levocabastine-insensitive neurotensin receptor

Properties:

E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays

Test:

A high affinity purification column was use to purify ELISA Kit for Neurotensin Receptor 1, (NTSR1) by Cloud Clone Corp by chromatographic size exclusion.ELISA Enzyme-linked immunosorbent assays Code 90320007 SNOMED

Stability:

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition. To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Description:

The receptors are ligand binding factors of type 1, 2 or 3 and protein-molecules that receive chemical-signals from outside a cell. When such chemical-signals couple or bind to a receptor, they cause some form of cellular/tissue-response, e.g. a change in the electrical-activity of a cell. In this sense, am olfactory receptor is a protein-molecule that recognizes and responds to endogenous-chemical signals, chemokinesor cytokines e.g. an acetylcholine-receptor recognizes and responds to its endogenous-ligand, acetylcholine. However, sometimes in pharmacology, the term is also used to include other proteins that are drug-targets, such as enzymes, transporters and ion-channels.